Mon, Apr 21, 2014, 10:02 AM EDT - U.S. Markets close in 5 hrs 58 mins

Recent

% | $
Quotes you view appear here for quick access.

ConocoPhillips Message Board

e7navy1999 198 posts  |  Last Activity: 49 minutes ago Member since: Jan 21, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Mr Kostaburger

    by e7navy1999 Feb 26, 2014 8:54 PM
    e7navy1999 e7navy1999 Mar 14, 2014 12:18 PM Flag

    Mr Kosta has an amazing crystal ball talent. Call was and is still a great horse. IKGH I keep adding every time it shows weakness. ZHNE struck gold not long ago as well

    Sentiment: Strong Buy

  • Reply to

    Earnings

    by e7navy1999 Mar 7, 2014 2:43 PM
    e7navy1999 e7navy1999 Mar 14, 2014 10:44 AM Flag

    UR Correct, Book value is well over double current share price. Cash on hand is near equal to market cap and revenue is 4X market cap. My strong sell was a mistake but I did pick up 500 more shares on the cheap

    Balance Sheet
    Total Cash (mrq): 56.71M
    Total Cash Per Share (mrq): 4.75
    Total Debt (mrq): 17.18M
    Total Debt/Equity (mrq): 19.95
    Current Ratio (mrq): 3.86
    Book Value Per Share (mrq): 7.21

  • Reply to

    Maybe We Haven't Heard From the KOLs

    by lovemyonvo Mar 13, 2014 9:16 PM
    e7navy1999 e7navy1999 Mar 14, 2014 9:18 AM Flag

    This sort of KOL research/testing requires a great deal of time and patience. I would rather they take their time and do all the right steps/processes to insure the absolute most accurate results. I am 99% confident that the KOL results will be mind blowing since the rush testing with common over the counter drugs was published as successful months ago. ONVO with good KOL results will likely hit $20-$25. However there is the 1% where we could see mixed results which would leave doubts. I look to see sideways trading to continue in the $8.50 to $10 ranges until news breaks. News could be very late Summer. I continue to add to my shares anytime ONVO comes close to $8.50

    Sentiment: Strong Buy

  • Reply to

    looks like two bucks is coming

    by bkfviking123 Mar 13, 2014 11:53 AM
    e7navy1999 e7navy1999 Mar 13, 2014 2:45 PM Flag

    I bet he sleeps in one of those luxury coffins with the music built in. The Board of director maybe still checks on him thinking he died already.

  • Reply to

    Seeking Alpo is all Lies

    by e7navy1999 Mar 11, 2014 10:38 AM
    e7navy1999 e7navy1999 Mar 13, 2014 9:09 AM Flag

    I see this morning ONVO update their FAQ board. It tells me that they do read our concerns regarding short/distort articles. Seeking Alpo better watch their tales. ONVO might chop it off!

  • Reply to

    Shorts sure are quiet!!

    by hunter82378 Mar 12, 2014 3:32 PM
    e7navy1999 e7navy1999 Mar 12, 2014 7:07 PM Flag

    If the 23% short is correct we are looking at a jump of $2-$3 after it hits between $10 and $12. could bust out to $14-$15 with the momentum

    Sentiment: Strong Buy

  • e7navy1999 e7navy1999 Mar 12, 2014 6:59 PM Flag

    Hey carib, actually at this price I have been buying more. About 500 shares per month added every month. SNFCA will someday see the light of day. We may have to wait for the son and some of the spineless board members to crock off or get terminated but the company is sound. Maybe even see Berkshire come in a take over this mismanaged company

  • e7navy1999 by e7navy1999 Mar 12, 2014 6:39 PM Flag

    Any company that can work this well even despite all the Obama #$%$-o-la deserves a round of applause

    Sentiment: Strong Buy

  • Reply to

    Mr Kostaburger

    by e7navy1999 Feb 26, 2014 8:54 PM
    e7navy1999 e7navy1999 Mar 12, 2014 5:05 PM Flag

    there she blows "CALL" There is oil in them there hills

    Sentiment: Strong Buy

  • e7navy1999 by e7navy1999 Mar 12, 2014 5:04 PM Flag

    there she blows. Oil well is blasting money!

    Sentiment: Strong Buy

  • Reply to

    Shorts sure are quiet!!

    by hunter82378 Mar 12, 2014 3:32 PM
    e7navy1999 e7navy1999 Mar 12, 2014 4:08 PM Flag

    Am I reading it right? Is ONVO 23% SHORT? Shorts are certainly crazy. News on third party testing should come out within the month. I myself have been adding to my position.

    Sentiment: Strong Buy

  • Reply to

    Up 12.25% on decent volume

    by geraldsimonsen Mar 12, 2014 2:56 PM
    e7navy1999 e7navy1999 Mar 12, 2014 3:39 PM Flag

    Any guess where we end out by COB today?

    Sentiment: Strong Buy

  • Reply to

    Mr Kostaburger

    by e7navy1999 Feb 26, 2014 8:54 PM
    e7navy1999 e7navy1999 Mar 12, 2014 3:34 PM Flag

    Mr Kostaburger: ZHNE cha-ching!!!! again. I'm back into CALL again as well. Thanks. Crossing fingers on MPO

    Sentiment: Strong Buy

  • e7navy1999 e7navy1999 Mar 12, 2014 10:28 AM Flag

    Shorts will be up against this: Dispute Seeking Alpha: (I found this article on the Motif site)
    Organovo's 3D Liver tissues exhibit several key features that remain stable over time:
    -- Tissue-like cellular density;

    -- Multi-layered architecture with multiple cell types positioned relative
    to one another, reaching up to 500 microns thickness, with tissues
    comprised of up to 20 cell layers;

    -- Albumin production 5-9 times greater than matched 2D controls, suggesting
    superior functionality;

    -- Stable albumin production for over 40 days, fibrinogen and transferrin
    production, and inducible cytochrome P450 enzymatic activities, including
    CYP 1A2 and CYP 3A4;

    -- Cholesterol biosynthesis, which has been demonstrated for the first time
    in a multi-cellular 3D human liver system in vitro;

    -- Evidence of the formation of tight junctions in the liver tissues,
    demonstrated by cadherin and claudin staining by day 3 of tissue
    formation; and

    -- Demonstration of appropriate response to hepatotoxic insults from
    acetaminophen, acetaminophen in combination with ethanol, and diclofenac.

    Partnerships include: Roche, Cell Therapeutics, Black Knight Cancer Institute, Worlds largest cosmetics company, Autodesk, National Institutes of Health (NIH), and the list goes on Less

    Sentiment: Strong Buy

  • Reply to

    Alarming, from SA Author

    by p_rimer Mar 12, 2014 9:02 AM
    e7navy1999 e7navy1999 Mar 12, 2014 9:05 AM Flag

    As regards certain other information outlets, Organovo continues to caution investors regarding the content of certain reports targeting existing and potential investors in its common stock, especially on certain internet sites. Organovo, like many other innovative technology companies, has been the subject of various articles on certain investor websites or from independent researchers that contain significant factual errors. The content of these reports can be submitted by independent authors, without any specific qualifications, experience or expertise required. In fact, most sites do little or no fact checking, provide little to no editorial oversight, and provide limited or no mechanisms for correction of factual errors.

    While some errors may be unintentional or simply sloppy, on some occasions it is possible that some authors may be following a "Short and Distort" strategy, where they purposefully create a negative picture after taking a short position. Organovo cautions investors to watch out for some telltale signs of a Short and Distort article or report, including articles that:
    Use phrases like "Trading Warning" or "Urgent" explicitly intended to cause fear and based on no new publicly released information about the Company;

    Sentiment: Strong Buy

  • Reply to

    Mr Kostaburger

    by e7navy1999 Feb 26, 2014 8:54 PM
    e7navy1999 e7navy1999 Mar 11, 2014 4:22 PM Flag

    I am back in CALL. lets hope earnings blows predictions out of the water

    Sentiment: Strong Buy

  • Reply to

    Another Hit Piece From Seeking Alpo

    by lovemyonvo Mar 11, 2014 9:05 AM
    e7navy1999 e7navy1999 Mar 11, 2014 1:06 PM Flag

    I put in another buy order at $8.70

  • Reply to

    Seeking Alpo is all Lies

    by e7navy1999 Mar 11, 2014 10:38 AM
    e7navy1999 e7navy1999 Mar 11, 2014 1:05 PM Flag

    anyone read this?

  • Reply to

    WAY Overvalued

    by p_rimer Mar 11, 2014 12:05 PM
    e7navy1999 e7navy1999 Mar 11, 2014 12:13 PM Flag

    way over valued: look at Amazon or Medbox and its 1700 P/E

  • Robert Baltera, Jr., M.S., M.B.A.

    Mr. Baltera is a seasoned pharmaceutical industry executive, who acquired a wealth of business and product management experience during 17 years with biotech pioneer Amgen
    James T. Glover, M.B.A., C.P.A.

    Mr. Glover, our audit committee chairman, was formerly Senior Vice President and Chief Financial Officer of Beckman Coulter, Inc., and was also Senior Vice President of Operations and Chief Financial Officer of Anadys Pharmaceuticals,
    Tamar D. Howson, M.S., M.B.A.

    Ms. Howson is a seasoned business development executive within the pharmaceutical industry. She currently serves as a corporate business development and strategy consultant to biopharmaceutical companies and she serves as a director at Idenix, Oxigene Pharmaceuticals, and Warner Chilcott. Previously, she was a member of the transaction advisory firm, JSB Partners. Prior to that, she was senior vice president of Corporate and Business Development at Lexicon. She was also senior vice president of Corporate and Business Development at Bristol Myers Squibb. Ms. Howson spent nine years at SmithKline Beecham
    Richard A. Heyman, Ph.D.

    Dr. Heyman is an experienced life science executive who is currently CEO of Aragon Pharmaceuticals, which he co-founded in 2009. Previously, Dr. Heyman was Chief Scientific Officer at Kalypsys, Inc., where he conducted drug discovery in therapeutic areas such as metabolic diseases, pain, and inflammation. In 1999, he co-founded and served as Chief Scientific Officer of X-Ceptor Therapeutics, a company that developed compounds targeting nuclear receptors for the treatment of metabolic diseases.

    Sentiment: Strong Buy

COP
74.770.0000(0.00%)10:02 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.